+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nootropics Market, By Type (Prescription v/s Over the Counter), By Product Type (Natural v/s Synthetic), By Distribution Channel (Online v/s Offline), By Application, By Region, Competition Forecast & Opportunities, 2026

  • PDF Icon

    Report

  • 114 Pages
  • December 2021
  • Region: Global
  • TechSci Research
  • ID: 5439254
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

Global nootropics market is projected to attain a significant growth in the forecast period, 2022-2026 with an impressive CAGR. The market growth can be attributed to the surging demand for the drugs and pharmaceuticals that support the brain’s cognitive functions. Moreover, the rapidly increasing demand for brain boosters and smart drugs among the student population is driving the growth of the global nootropics market in the upcoming five years. The students are inclined toward nootropics as these improve cognitive function, such as executive functions, memory, creativity, or motivation. The rising awareness about these drugs is supporting the growth of the global nootropics market in the next five years. Although the ethical issues regarding the use of nootropics drugs by the healthy individual may put some restraint over the growth of the global nootropics market in future. In the year, 2019 the United States Food and Drug Administration and Federal Trade Commission warned the manufacturers and market players involved in the advertisements, about the probable advertisement fraud and marketing scams related to nootropics substances. The issue of substance abuse is also a major concern regarding the drug, although regulatory sales and prospective warnings are anticipated to support the future growth of the global nootropics market in the future five years of forecast, until 2026.



Nootropics are the drugs, supplements and related components that are expected to work efficiently in increasing and enhancing brain activities like cognitive thinking, executive functioning of the brain, higher memory retention, and creating senses of healthy motivation for the individuals. Patients suffering from mood swings, depression, lack of attention and focus, and sleep disorders are often prescribed nootropics for their recovery. Nootropics are often associated with the term “smart drugs” for their functions and effect on the patients.



The global nootropics market is segmented by type, product type, distribution channel, application, regional distribution, and competitional analysis. Based on type, the market is further bifurcated into prescription and over the counter nootropics drugs. Prescription nootropics are anticipated to hold the largest revenue share of the market and assert their dominance over the market in the upcoming five years on account of rapidly increasing cases of depression, mood swings, anxiety and stress. The patients suffering from such mental health issues are able to control their symptoms these drugs as these help them to facilitate their thoughts. Also, concerned legalities and ethical issues have made it essential for the prescription to be produced to purchase the nootropics thereby supporting the growth of the global nootropics market in the next five years.



Holding the major shares of the global nootropics market are Accelerated Intelligence Inc., AlternaScript LLC, Onnit Labs, Inc., Peak Nootropics LLC, Teva Pharmaceutical Industries Ltd., Purelife bioscience Co., Ltd, SupNootropic bio co., Ltd, Cephalon, Inc., United Pharmacies (UK) Ltd., Nootrobox Inc. (HVMN), among others. Market players are actively involved in the research and product development. The advanced technology has made it possible for the industry to provide excellent services through nootropics drugs. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.



Years considered for this report:

  • Historical Years: 2016 - 2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022 - 2026

Objective of the Study:

  • To analyze the historical growth in the market size of global nootropics market from 2016 to 2020.
  • To estimate and forecast the market size of global nootropics market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global nootropics market based on type, product type, distribution channel, application, competitional landscape, and regional distribution.
  • To identify dominant region or segment in the global nootropics market.
  • To identify drivers and challenges for global nootropics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global nootropics market.
  • To identify and analyze the profile of leading players operating in global nootropics market.
  • To identify key sustainable strategies adopted by market players in global nootropics market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of manufacturers, suppliers, and distributors across the global. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the manufactures which could not be identified due to the limitations of secondary research. The publisher analyzed the manufactures, distribution channels and presence of all major players across the globe.



The publisher calculated the market size of global nootropics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.



Key Target Audience:

  • Manufacturers, end users, and other stakeholders
  • Distributors and suppliers of nootropics and other stakeholders
  • Organizations, forums, and alliances related to nootropics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.



Report Scope:


In this report, global nootropics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:



Global Nootropics Market, By Type:

  • Prescription
  • Over the Counter

Global Nootropics Market, By Product Type:

  • Natural
  • Synthetic

Global Nootropics Market, By Distribution Channel:

  • Online
  • Offline

Global Nootropics Market, By Application:

  • Memory Enhancement
  • Mood & Depression
  • Attention & Focus
  • Longevity & Anti-aging
  • Sleep & Recovery
  • Anxiety
  • Others

Global Nootropics Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • South America
  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global nootropics market.



Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.




This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview2. Research Methodology3. Impact of COVID-19 on Global Nootropics Market4. Voice of Customer5. Executive Summary
6. Global Nootropics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Prescription v/s Over the Counter)
6.2.2. By Product Type (Natural v/s Synthetic)
6.2.3. By Distribution Channel (Online v/s Offline)
6.2.4. By Application (Memory Enhancement, Mood & Depression, Attention & Focus, Longevity & Anti-aging, Sleep & Recovery, Anxiety, Others)
6.2.5. By Region
6.2.6. By Company (2020)
6.3. Product Market Map
7. North America Nootropics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Product Type
7.2.3. By Distribution Channel
7.2.4. By Application
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Nootropics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Product Type
7.3.1.2.3. By Distribution Channel
7.3.1.2.4. By Application
7.3.2. Mexico Nootropics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Product Type
7.3.2.2.3. By Distribution Channel
7.3.2.2.4. By Application
7.3.3. Canada Nootropics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Product Type
7.3.3.2.3. By Distribution Channel
7.3.3.2.4. By Application
8. Europe Nootropics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Product Type
8.2.3. By Distribution Channel
8.2.4. By Application
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. France Nootropics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Product Type
8.3.1.2.3. By Distribution Channel
8.3.1.2.4. By Application
8.3.2. United Kingdom Nootropics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Product Type
8.3.2.2.3. By Distribution Channel
8.3.2.2.4. By Application
8.3.3. Italy Nootropics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Product Type
8.3.3.2.3. By Distribution Channel
8.3.3.2.4. By Application
8.3.4. Germany Nootropics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Product Type
8.3.4.2.3. By Distribution Channel
8.3.4.2.4. By Application
8.3.5. Spain Nootropics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Product Type
8.3.5.2.3. By Distribution Channel
8.3.5.2.4. By Application
9. Asia-Pacific Nootropics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Product Type
9.2.3. By Distribution Channel
9.2.4. By Application
9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Nootropics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Product Type
9.3.1.2.3. By Distribution Channel
9.3.1.2.4. By Application
9.3.2. India Nootropics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Product Type
9.3.2.2.3. By Distribution Channel
9.3.2.2.4. By Application
9.3.3. Japan Nootropics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Product Type
9.3.3.2.3. By Distribution Channel
9.3.3.2.4. By Application
9.3.4. Australia Nootropics Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Type
9.3.4.2.2. By Product Type
9.3.4.2.3. By Distribution Channel
9.3.4.2.4. By Application
9.3.5. South Korea Nootropics Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Type
9.3.5.2.2. By Product Type
9.3.5.2.3. By Distribution Channel
9.3.5.2.4. By Application
10. South America Nootropics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Product Type
10.2.3. By Distribution Channel
10.2.4. By Application
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Nootropics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Product Type
10.3.1.2.3. By Distribution Channel
10.3.1.2.4. By Application
10.3.2. Argentina Nootropics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Product Type
10.3.2.2.3. By Distribution Channel
10.3.2.2.4. By Application
10.3.3. Colombia Nootropics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Product Type
10.3.3.2.3. By Distribution Channel
10.3.3.2.4. By Application
11. Middle East and Africa Nootropics Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Type
11.2.2. By Product Type
11.2.3. By Distribution Channel
11.2.4. By Application
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Nootropics Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Type
11.3.1.2.2. By Product Type
11.3.1.2.3. By Distribution Channel
11.3.1.2.4. By Application
11.3.2. UAE Nootropics Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Type
11.3.2.2.2. By Product Type
11.3.2.2.3. By Distribution Channel
11.3.2.2.4. By Application
11.3.3. Saudi Arabia Nootropics Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Type
11.3.3.2.2. By Product Type
11.3.3.2.3. By Distribution Channel
11.3.3.2.4. By Application
11.3.4. Kuwait Nootropics Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Type
11.3.4.2.2. By Product Type
11.3.4.2.3. By Distribution Channel
11.3.4.2.4. By Application
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Accelerated Intelligence Inc.
14.2. AlternaScript LLC
14.3. Onnit Labs, Inc.
14.4. Peak Nootropics LLC
14.5. Teva Pharmaceutical Industries Ltd.
14.6. Purelife bioscience Co., Ltd
14.7. SupNootropic bio co., Ltd
14.8. Cephalon, Inc.
14.9. United Pharmacies (UK) Ltd.
14.10. Nootrobox Inc. (HVMN)
15. Strategic Recommendations16. About Us & Disclaimer

Companies Mentioned

  • Accelerated Intelligence Inc
  • AlternaScript LLC
  • Onnit Labs, Inc
  • Peak Nootropics LLC
  • Teva Pharmaceutical Industries Ltd
  • Purelife bioscience Co, Ltd
  • SupNootropic bio co, Ltd
  • Cephalon, Inc
  • United Pharmacies (UK) Ltd
  • Nootrobox Inc (HVMN)